We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Supermix Controls to Streamline QC in Clinical Laboratories

By LabMedica International staff writers
Posted on 20 Mar 2014
Print article
Image: The two new liquid assayed quality controls from Randox are supermix combinations of multiple controls for streamlining QC in clinical laboratories (Photo courtesy of Randox).
Image: The two new liquid assayed quality controls from Randox are supermix combinations of multiple controls for streamlining QC in clinical laboratories (Photo courtesy of Randox).
Two new liquid assayed chemistry controls have been designed to streamline quality control (QC) by cutting the number of individual QCs a laboratory needs to run in routine medical testing, saving time and money while ensuring highly accurate results and patient diagnosis.

The two new controls, Acusera liquid assayed Liquid Chemistry Premium and Liquid Chemistry Premium Plus from Randox Laboratories (Antrim, North Ireland, UK), enable laboratories to run QC on up to 100 analytes all within one test, without compromising performance or accuracy. The concept of offering multianalyte controls is not new; however, these latest assayed controls from Randox are the most comprehensive on the world market to date, containing a unique supermix combination of proteins, lipids, immunoassays, cardiac markers, blood markers, therapeutic drugs, and routine chemistry analytes.

Available in 3 concentration levels (low, mid, and high), Premium Plus covers a very broad clinical range, removing the need for laboratories to purchase additional, often expensive, low or high level controls. The Acusera Liquid Chemistry Premium Plus control contains 100 analytes, while the Acusera "Liquid Chemistry Premium" control offers 91, with the following features. The high levels of CRP and other key proteins included eliminate the need for multiple controls, dramatically streamlining QC. They are assayed controls, providing clinically significant values for a wide range of analyzers at key decision points. Both controls are liquid for ease of use, eliminating possible reconstitution errors and improving lab efficiency. The controls are highly stable when stored at -20 °C to -70 °C, with open vial stability of up to 7 days at 2–8 °C, reducing wastage in laboratories. They are manufactured using human-based serum, ensuring performance that closely mirrors patient samples.

As true third party controls, laboratories are far better assured of unbiased, independent assessment of analytical performance and as such help deliver highly accurate results and patient diagnosis.

"These new assayed controls will be hugely beneficial to medical laboratories running a wide range of routine patient tests, allowing them to consolidate all or the majority of their QC within one control," said Dr. John Campbell, PhD. Steven Jordan, Randox’s Global Manager for QC, said, "Randox reputation as a leading global provider of quality controls takes another step forward with the launch of Acusera Liquid Chemistry Premium and Premium Plus. We’re delighted to be pushing the boundaries of quality control, helping laboratories improve their performance and productivity whilst ensuring highly accurate results and improving patient diagnosis."

The controls are now available in the UK, Europe, Middle East, Far East, and Africa. Randox is currently awaiting product approval from the US FDA and China SFDA.

Related Links:

Randox Laboratories
Acursera Liquid QC  


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more